BriaCell Therapeutics BCTX Stock
BriaCell Therapeutics Price Chart
BriaCell Therapeutics BCTX Financial and Trading Overview
| BriaCell Therapeutics stock price | 5 USD |
| Previous Close | 5.9 USD |
| Open | 5.81 USD |
| Bid | 0 USD x 1800 |
| Ask | 0 USD x 1100 |
| Day's Range | 5.74 - 6.1 USD |
| 52 Week Range | 4.23 - 8.37 USD |
| Volume | 84.55K USD |
| Avg. Volume | 117.92K USD |
| Market Cap | 96.98M USD |
| Beta (5Y Monthly) | 1.665847 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.75 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25 USD |
BCTX Valuation Measures
| Enterprise Value | 62.87M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.2978725 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.269 |
Trading Information
BriaCell Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.665847 |
| 52-Week Change | 8.40% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.37 USD |
| 52 Week Low | 4.23 USD |
| 50-Day Moving Average | 6.66 USD |
| 200-Day Moving Average | 6.47 USD |
BCTX Share Statistics
| Avg. Volume (3 month) | 117.92K USD |
| Avg. Daily Volume (10-Days) | 82.77K USD |
| Shares Outstanding | 15.98M |
| Float | 11.2M |
| Short Ratio | 8.7 |
| % Held by Insiders | 23.69% |
| % Held by Institutions | 15.14% |
| Shares Short | 1.26M |
| Short % of Float | 9.13% |
| Short % of Shares Outstanding | 7.91% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:300 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | July 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.086% |
| Return on Equity (ttm) | -309.72% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -19231526 USD |
| Net Income Avi to Common (ttm) | -23454228 USD |
| Diluted EPS (ttm) | -0.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 33.5M USD |
| Total Cash Per Share (mrq) | 2.16 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 50.623 |
| Book Value Per Share (mrq) | -0.083 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15643690 USD |
| Levered Free Cash Flow (ttm) | -8932643 USD |
Profile of BriaCell Therapeutics
| Country | United States |
| State | BC |
| City | West Vancouver |
| Address | Bellevue Centre |
| ZIP | V7T 2X1 |
| Phone | N/A |
| Website | https://www.briacell.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development agreement with the National Cancer Institute to conduct preclinical studies to develop and test Bria-OTS cellular immunotherapy as a treatment for cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Q&A For BriaCell Therapeutics Stock
What is a current BCTX stock price?
BriaCell Therapeutics BCTX stock price today per share is 5 USD.
How to purchase BriaCell Therapeutics stock?
You can buy BCTX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BriaCell Therapeutics?
The stock symbol or ticker of BriaCell Therapeutics is BCTX.
Which industry does the BriaCell Therapeutics company belong to?
The BriaCell Therapeutics industry is Biotechnology.
How many shares does BriaCell Therapeutics have in circulation?
The max supply of BriaCell Therapeutics shares is 3.71M.
What is BriaCell Therapeutics Price to Earnings Ratio (PE Ratio)?
BriaCell Therapeutics PE Ratio is now.
What was BriaCell Therapeutics earnings per share over the trailing 12 months (TTM)?
BriaCell Therapeutics EPS is -4.75 USD over the trailing 12 months.
Which sector does the BriaCell Therapeutics company belong to?
The BriaCell Therapeutics sector is Healthcare.
BriaCell Therapeutics BCTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
- {{ link.label }} {{link}}